Our study demonstrated that HTLV-1 preferentially targets CD4+ T cells over CD8+ T cells, with significantly reduced expression of the CD3 and TCR complex on CD4+ T cells in HAM patients compared to HCs. The gene discussed is CD8A; the disease is tropical spastic paraparesis.